Harmony Biosciences Holdings Inc
HRMY · NASDAQ
Harmony Biosciences Holdings, Inc. operates as a pharmaceutical company. The Company focuses on the research, drug development, and treatment for neurologic disorder of sleep-wake state instability. Harmony Biosciences Holdings serves patients in the United States.
ESG Scores
Overall ESG4.5
Environmental2.4
Social3.3
Governance5.4
Gender Diversity
Female Directors0.125%
Female Executives0.12371134020618557%
CEO GenderMale
Market Data
Price$36.84+3.34 (+9.97%)
Market Cap—
P/E Ratio—
EPS$—
52W High$—
52W Low$—
Beta—